Please use this identifier to cite or link to this item:
http://doi.org/10.25358/openscience-5870
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wild, Johannes | - |
dc.contributor.author | Wenzel, Philip | - |
dc.date.accessioned | 2021-05-19T10:39:25Z | - |
dc.date.available | 2021-05-19T10:39:25Z | - |
dc.date.issued | 2021 | - |
dc.identifier.uri | https://openscience.ub.uni-mainz.de/handle/20.500.12030/5879 | - |
dc.description.abstract | Although essential hypertension affects a large proportion of the human population and is one of the key drivers of cardiovascular mortality worldwide, we still do not have a complete understanding of its pathophysiology. More than 50 years ago, the immune system has been identified as an important part of the pathogenesis of arterial hypertension. An exceeding variety of recent publications deals with the interplay between the numerous different components of the immune system and mechanisms of arterial hypertension and has substantially contributed to our understanding of the role of immunity and inflammation in the pathogenesis of the disease. In this review, we focus on myeloid cells and anatomical barriers as particular aspects of innate immunity in arterial hypertension. Since it represents a first line of defense protecting against pathogens and maintaining tissue homeostasis, innate immunity provides many mechanistic hinge points in the area of hypertension. | en_GB |
dc.language.iso | eng | de |
dc.rights | CC BY | * |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | * |
dc.subject.ddc | 610 Medizin | de_DE |
dc.subject.ddc | 610 Medical sciences | en_GB |
dc.title | Myeloid cells, tissue homeostasis, and anatomical barriers as innate immune effectors in arterial hypertension | en_GB |
dc.type | Zeitschriftenaufsatz | de |
dc.identifier.doi | http://doi.org/10.25358/openscience-5870 | - |
jgu.type.dinitype | article | en_GB |
jgu.type.version | Published version | de |
jgu.type.resource | Text | de |
jgu.organisation.department | FB 04 Medizin | de |
jgu.organisation.number | 2700 | - |
jgu.organisation.name | Johannes Gutenberg-Universität Mainz | - |
jgu.rights.accessrights | openAccess | - |
jgu.journal.title | Journal of molecular medicine | de |
jgu.journal.volume | 99 | de |
jgu.pages.start | 315 | de |
jgu.pages.end | 326 | de |
jgu.publisher.year | 2021 | - |
jgu.publisher.name | Springer | de |
jgu.publisher.place | Berlin u.a. | de |
jgu.publisher.uri | https://doi.org/10.1007/s00109-020-02019-1 | de |
jgu.publisher.issn | 1432-1440 | de |
jgu.organisation.place | Mainz | - |
jgu.subject.ddccode | 610 | de |
jgu.publisher.doi | 10.1007/s00109-020-02019-1 | |
jgu.organisation.ror | https://ror.org/023b0x485 | |
Appears in collections: | JGU-Publikationen |
Files in This Item:
File | Description | Size | Format | ||
---|---|---|---|---|---|
wild_johannes-myeloid_cells-20210430210756292.pdf | 708.86 kB | Adobe PDF | View/Open |